| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NKGN | Common Stock | Other | $0 | -97,232 | -4% | $0.000000 | 2,339,512 | 02 Dec 2024 | Direct | F1, F3 |
| transaction | NKGN | Common Stock | Other | $0 | -83,214 | -3.6% | $0.000000 | 2,256,298 | 16 Dec 2024 | Direct | F2, F3 |
| transaction | NKGN | Common Stock | Other | $0 | -110,157 | -4.9% | $0.000000 | 2,146,141 | 18 Dec 2024 | Direct | F3, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NKGN | Private Placement Warrants | Disposed to Issuer | -713,357 | -15% | 4,008,176 | 02 Dec 2024 | Common Stock | 713,357 | $11.50 | Direct | F3, F5 | ||
| transaction | NKGN | Private Placement Warrants | Disposed to Issuer | -1,212,707 | -30% | 2,795,469 | 16 Dec 2024 | Common Stock | 1,212,707 | $11.50 | Direct | F3, F5 | ||
| transaction | NKGN | Working Capital Warrants | Disposed to Issuer | -66,667 | -13% | 456,473 | 16 Dec 2024 | Common Stock | 66,667 | $11.50 | Direct | F3, F6 | ||
| transaction | NKGN | Private Placement Warrants | Disposed to Issuer | -891,696 | -32% | 1,903,773 | 18 Dec 2024 | Common Stock | 891,696 | $11.50 | Direct | F3, F5 | ||
| transaction | NKGN | Working Capital Warrants | Disposed to Issuer | -266,667 | -58% | 189,806 | 18 Dec 2024 | Common Stock | 266,667 | $11.50 | Direct | F3, F6 |
| Id | Content |
|---|---|
| F1 | On December 2, 2024, Graf Acquisition Partners IV LLC (the "Sponsor") distributed 97,232 shares of common stock of the NKGen Biotech, Inc. (f/k/a Graf Acquisition Corp. IV, the "Issuer") to SPAC21, LLC, Claybaker LLC, and Venus Investments I LLC, each a member of the Sponsor and initially entitled to the distribution of 15% of the original shares of common stock held by the Sponsor, which were issued upon the conversion of the shares of Class B common stock of Graf Acquisition Corp. IV (the "Founder Shares"), upon September 29, 2024, the one-year anniversary of the closing of the business combination between Graf Acquisition Corp. IV and the Issuer, and the additional parties thereto (the "Closing"). |
| F2 | On December 16, 2024, the Sponsor distributed 83,214 shares of common stock of the Issuer to ARI Founders Fund, L.P. and OC Opportunities Fund III, L.P, each a member of the Sponsor and initially entitled to the distribution of 15% of the Founder Shares, upon September 29, 2024, the one-year anniversary of the Closing. |
| F3 | The Sponsor is the record holder of the securities reported herein. James A. Graf is the managing member of the Sponsor. Mr. Graf has voting and investment discretion with respect to the securities held of record by the Sponsor. |
| F4 | On December 17, 2024, the Sponsor distributed 110,157 shares of common stock of the Issuer to Magnetar Constellation Master Fund, Ltd., Magnetar Constellation Fund II, Ltd., Magnetar Structured Credit Fund, LP, Magnetar Xing He Master Fund Ltd., Magnetar SC Fund Ltd., Purpose Alternative Credit Fund Ltd., Purpose Alternative Credit Fund - T LLC, Magnetar Lake Credit Fund LLC, Magnetar Capital Master Fund, Ltd., Magnetar Discovery Master Fund Ltd., W.I. Cook Foundation Inc., Isalea Investments LP, Edwin J. Rigaud, and Jeff Sagansky, each a member of the Sponsor and initially entitled to the distribution of 15% of the Founder Shares, upon September 29, 2024, the one-year anniversary of the Closing. |
| F5 | The Private Placement Warrants were distributed by the Sponsor to its members in accordance with its limited liability company agreement, as amended. The Private Placement Warrants were initially purchased at a price of $1.50 per Private Placement Warrant in accordance with the private placement warrant agreement between the Sponsor and the Issuer. |
| F6 | The Working Capital Warrants were distributed by the Sponsor to its members in accordance with its limited liability company agreement, as amended. The Working Capital Warrants were issued in connection with the conversion of working capital loans, entered into between the Sponsor and the Issuer, at a price of $1.50 per Working Capital Warrant. |